What is Charles River Laboratories International Dividend Yield %?
As of today (2024-04-24), the Trailing Annual Dividend Yield of Charles River Laboratories International is 0.00%.
The historical rank and industry rank for Charles River Laboratories International's Dividend Yield % or its related term are showing as below:
CRL's Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.055 * Ranked among companies with meaningful Dividend Yield % only.
Charles River Laboratories International's Dividend Payout Ratio for the
three
months ended in Dec. 2023 was 0.00.
As of today (2024-04-24), the Forward Dividend Yield % of Charles River Laboratories International is 0.00%.
Charles River Laboratories International's Dividends per Share for the
three
months ended in Dec. 2023 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Charles River Laboratories International Dividend Yield % Historical Data
The historical data trend for Charles River Laboratories International's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Charles River Laboratories International Dividend Yield % Chart
Charles River Laboratories International Annual Data
Competitive Comparison of Charles River Laboratories International's Dividend Yield %
For the Diagnostics & Research subindustry, Charles River Laboratories International's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Dividend Yield % falls into.
Charles River Laboratories International Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Charles River Laboratories International (NYSE:CRL) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Charles River Laboratories International Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Charles River Laboratories International's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles River Laboratories International (Charles River Laboratories International) Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRL has been successfully added to your 